Chris O Brien Lifehouse

Camperdown, Australia

We are pleased to announce that Chris O’Brien Lifehouse in Camperdown, Australia, has achieved IASIOS Accredited Centre status, becoming the second facility in the country to earn this recognition.

Under the leadership of Dr. Chris Rogan, the team has shown outstanding dedication to delivering high-quality, structured care in interventional oncology and to setting a benchmark for excellence in the region.

We congratulate the entire team on this significant achievement and welcome them to the growing network of IASIOS Accredited Centres.

King Faisal Specialist Hospital & Research Center

Riyadh, Saudi Arabia

We are pleased to welcome King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia, as an Enrolled Centre in the IASIOS community. This step reflects the team’s strong commitment to delivering standardised, high-quality care in interventional oncology.

We look forward to supporting them as they move forward on their accreditation journey.

Hospital da Universidade de Coimbra

Coimbra, Portugal

We are pleased to share that Hospital da Universidade de Coimbra in Portugal has been recognised as an IASIOS Accredited Centre. This achievement confirms that its interventional oncology service meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

Under the leadership of Prof. Dr. Paulo Donato, the team has shown outstanding dedication to structured, patient-centred care and continuous quality improvement.

We warmly congratulate them on this accomplishment and welcome them to the expanding network of IASIOS Accredited Centres.

Kantonsspital Winterthur

Winterthur, Switzerland

We are delighted to announce that Kantonsspital Winterthur in Switzerland has been recognized as an IASIOS Centre of Excellence, joining a growing group of leading institutions worldwide that have achieved this prestigious distinction.

The Centre of Excellence designation represents the highest level of recognition within IASIOS, confirming that Kantonsspital Winterthur meets both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

This achievement reflects a fully integrated and meticulously structured interventional oncology pathway, ensuring that every patient receives consistent, safe, and high-quality care. From staff competence and multidisciplinary collaboration to facility infrastructure and radiation safety, Kantonsspital Winterthur demonstrates excellence across every aspect of its IO service.

We commend the dedication and leadership of PD Dr. med. Arash Najafi, Ms. Annmarie Monard, Mr. Patrick Martin, and Mr. Johannes Lauinger, whose commitment to quality and patient-centred care has been instrumental in reaching this milestone.

Their accomplishment marks a significant contribution to advancing standards in interventional oncology and stands as an inspiration to the global IO community.

Dr. Arash Najafi

IASIOS Council Member

(Kantonsspital Winterthur, Switzerland)

General University Hospital of Patras

Patras, Greece

We welcome General University Hospital of Patras in Greece as an Enrolled Centre in the IASIOS community. This enrolment reflects a clear commitment to quality, structure, and continuous improvement in interventional oncology through the IASIOS accreditation pathway.

We look forward to supporting their team as they advance through the accreditation process.

Dr. Konstantinos Katsanos

IASIOS Council Member

(Patras University Hospital, Greece)

Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Italy

We are delighted to announce that Fondazione Policlinico Universitario Campus Bio-Medico from Italy has become an IASIOS Accredited Centre. This confirms that the hospital’s interventional oncology service line meets the highest international standards of standardisation and quality. Under the leadership of Prof. Rosario Francesco Grasso, the team has demonstrated a strong commitment to providing safe, consistent, and patient-centred care while pursuing continuous improvement.

The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital

Amsterdam, Netherlands

We are proud to announce that The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital has achieved the status of IASIOS Accredited Centre. This achievement demonstrates that its interventional oncology service fulfils the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. Led by Dr. Tarik Baetens, the team has displayed strong dedication to delivering structured, patient-focused care and maintaining continuous quality improvement. We congratulate them on this important milestone.

University Hospital Tübingen

Tübingen, Germany

We are pleased to welcome University Hospital Tübingen – Diagnostic and Interventional Radiology as a new IASIOS Enrolled Centre in Germany. This step reflects the team’s commitment to strengthening quality and consistency in interventional oncology through a structured accreditation framework. We look forward to supporting the team as they progress toward IASIOS accreditation.

Baptist Health Miami Cancer Institute

Miami, Florida

We proudly welcome Baptist Health Miami Cancer Institute as an Enrolled Centre. Under the leadership of Dr. Govindarajan Narayanan, this step reflects their dedication to delivering high-quality, multidisciplinary cancer care and advancing the field of interventional oncology. We are glad to see the IASIOS presence expand in North America and look forward to supporting the team as they progress through the accreditation pathway.

SLK Kliniken Heilbronn GmbH

Heilbronn, Germany

We are proud to announce that SLK Kliniken Heilbronn in Germany has been recognized as an IASIOS Centre of Excellence, becoming the third centre worldwide and the very first in Germany to achieve this distinction.

The Centre of Excellence designation is the highest level of recognition within IASIOS, confirming that SLK Kliniken Heilbronn fulfils both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. This recognition means that the entire interventional oncology patient pathway at the centre follows a systematic and structured approach, where every patient receives consistent and high-quality care. Staff competence, advanced facility infrastructure, precise treatment delivery, and rigorous standards of radiation safety are all upheld at the highest international level.

We commend the dedication and commitment of Prof. Pereira, Prof. Grözinger, Dr. Speck, Dr. Mayer, Mr. Hermann, Dr. Wandschneider and the entire interventional radiology team at SLK Kliniken Heilbronn. Their achievement represents an outstanding contribution to clinical quality in interventional oncology and serves as an inspiration to the global IO community.

Dr. Sina Speck

IASIOS Council Member

(SLK-Kliniken Heilbronn, Germany)